Entity > Corporation > AU > Melbourne Victoria > Immutep
About Immutep
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Immutep
| Company Attribute | Value |
| Address | StreetAddress: 33 Australia Sq L 264, AddressLocality: Sydney, AddressRegion: New South Wales, PostalCode: 2000, AddressCountry: Australia |
| Founding Date | 2001 |
| Name | Immutep |
| Number Of Employees | 35 |
| Revenue | $4,252,000 USD |
| Ticker Symbol | NASDAQ: IMMP |
| Url | immutep |
| Wikipedia | wikipedia |
| Wikidata | wikidata |
Immutep
Melbourne, AU
26 Aug 2023
Immutep
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.immutep.com/
Immutep is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases.
Rich Sitelinks
https://au.linkedin.com › company › immutep-ltd
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of ...
https://en.wikipedia.org › wiki › Immutep
Immutep Ltd (formerly Prima Biomed) is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control ...
https://twitter.com/Immutep?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://finance.yahoo.com › quote › IMMP
Find the latest Immutep Limited (IMMP) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.facebook.com/Immutep/
Immutep Limited, The Rocks, Sydney. 767 likes · 12 talking about this · 3 were here. Immutep is the global leader in developing LAG-3 therapeutics (ASX:...
https://www.marketwatch.com › investing › stock › immp
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and ...
https://www.afr.com › street-talk › fundies-pile-into-imm...
4 June 2023 — Immutep fell 13.3 per cent on Friday to close at 26¢ per share. Sarah Thompson has co-edited Street Talk since 2009, specialising in private ...
https://www.afr.com/street-talk/immutep-in-80m-raise-bells-jefferies-and-wilsons-on-ticket-20230531-p5dcu5
31 May 2023 — Listed immunotherapy biotech Immutep will have fund managers appraising its cancer treatments this week, as the business rattles the tin to ...
https://www.marketindex.com.au › asx › imm
Immutep Limited (IMM, Prima BioMed Ltd) is a globally active biotechnology company that is a leader in the development of LAG-3 immunotherapeutic products ...
Related Searches
immutep future
immutep breast cancer
immutep buyout
Knowledge Panel
Immutep (Biotechnology company)
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech.
-
Stock price : IMM (ASX) $0.28 +0.01 (+3.77%)25 Aug, 4:10 pm AEST - Disclaimer
-
Headquarters : New South Wales
-
Subsidiaries : Immutep S.A., Cancer Vac Pty Ltd, Panvax Ltd., Oncomab, Ltd.
-
Founded : 2001
| Entity Home | Kalicube Pro Entity Page |